Exsure

Bhubaneswar, India Founded: 2021 • Age: 5 yrs
Developer of nano drug delivery platform for cancer treatment

About Exsure

Exsure is a Healthcare company based in Bhubaneswar (India) founded in 2021 by Swastika Paul and Abhishek Dutta. Developer of nano drug delivery platform for cancer treatment. Exsure has raised $346.88 thousand across 1 funding round from investors including Unicorn India Ventures. The company has 1 employees. Its chief executive, as recorded, is Abhishek Dutta. Its Indian entity Exsure Private Limited reported revenue of β‚Ή7.4 Lakh. Exsure offers products and services including EXOSURE, LEUCOSURE, and DENDROSURE. Its focus areas include Life Sciences, Oncology, Drugs and Diversified.

Company details

Exsure was founded in 2021 and is based in Bhubaneswar, India. Operations are centered in the biotechnology sector, where an exosome-based platform for chemotherapeutic drug delivery is being developed. Anti-cancer drugs are targeted precisely to tumor and relapse-causing cells through this technology, minimizing impact on healthy cells. The focus remains on advancing nano-scale solutions for oncology applications.

  • Headquarters Bhubaneswar, India
  • Employees 1
  • Founders Swastika Paul, Abhishek Dutta
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website exsure.in
  • Social LinkedIn X Facebook YouTube
  • Legal Name Exsure Private Limited
  • Date of Incorporation 18 Nov, 2021
  • Jurisdiction Bhubaneswar, Odisha, India
Key Metrics
  • Annual Revenue
    ₹7.4 Lakh

    FY 2025 · -74% YoY

  • Net Loss
    -₹14.2 Lakh

    FY 2025 · -191% margin

  • EBITDA
    -₹13.7 Lakh

    FY 2025 · -185% margin

  • Total Equity Funding
    $346.88K (USD)

    in 1 rounds

  • Latest Funding Round
    $346.88K (USD), Seed

    Jan 2025

  • Investors
  • Employee Count
    1

Products & Services of Exsure

Exsure offers a comprehensive portfolio of products and services, including EXOSURE, LEUCOSURE, and DENDROSURE.

EXOSURE
Reagent

Reagent for isolating exosomes from blood and cell-culture.

LEUCOSURE
Reagent

Lymphocyte separation reagent for blood samples.

DENDROSURE
Culture Medium

Medium to convert monocytes into mature dendritic cells.

Apps and channels of Exsure

its YouTube channel EXSURE has 32 subscribers and 15 videos.

EXSURE
YouTube 32 subscribers 15 videos Science & Technology
Open channel

Videos from Exsure

The most watched videos on Exsure's YouTube channel, EXSURE (32 subscribers). Click a video to play it here.

Breast Cancer Awareness Seminar 2023 by Dr Mandira Saha Mallik
215 views
Exosure Total Exosome Isolation Reagent (Cell culture media) #madeinindia
179 views
Introducing Exsure and how we are trying to solve the global problem of breast cancer.
163 views
WHAT IS MELATONIN? Get to know about its effect and how #melatonin #supplements can help you.
102 views

More on EXSURE.

Funding Insights of Exsure

Exsure has successfully raised a total of $346.88K through 1 strategic funding round. The most recent funding activity was a Seed round of $346.88 thousand completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $346,878
  • Total Rounds 1
  • Last Round Seed β€” $346,878
  • First Round $346,878

    (Jan 2025)

  • Investors Count 1

All 1 funding rounds of Exsure with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2025$346,878Seed–Unicorn India Ventures
–
Valuation history

1 investors in total: 1 institutional.

Investors in Exsure

Exsure has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Unicorn India Ventures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Venture capital firm offering seed funding and support to startups in technology and innovation sectors.
2014unicornivc.comMumbai, India
Premium access

Investor details for Exsure

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Exsure Private Limited (Exsure)

Exsure Private Limited is the primary company behind Exsure. The board of Exsure Private Limited currently have 2 directors; the longest-serving is Abhishek Dutta, appointed in 2021.

DirectorDesignationAppointedTenureEntity
Abhishek Dutta
DIN 09405669
Director18 Nov 20215 yrsExsure Private Limited
Swastika Paul
DIN 09405670
Director18 Nov 20215 yrsExsure Private Limited

People of Exsure

2 people are tracked at Exsure (2 in leadership); the tracked headcount is 1.

NameRoleGroup
Co-FounderLeadership
Co-Founder & CEOLeadership
Premium access

Complete people profiles for Exsure

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Exsure

Figures of Exsure Private Limited, the primary company behind Exsure, for FY 2025. Revenue was ₹7.4 Lakh (-74% year on year). Net loss was -₹14.2 Lakh (-191% margin). EBITDA was -₹13.7 Lakh (-185% margin).

  • ₹7.4 LakhRevenue · FY 2025 · -74% YoY
  • -₹14.2 LakhNet loss · -191% margin
  • -₹13.7 LakhEBITDA · -185% margin
  • ₹64,900Paid-up capital

Balance sheet, profit and loss, cash flow and ratios of Exsure Private Limited are on its company page.

Premium access

Detailed financial statements for Exsure

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Exsure

2 dated milestones of Exsure across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Exsure is founded.
  2. Funding First funding round of $347K.

Web traffic of Exsure

The website of Exsure (exsure.in) receives about 9.8K visits a month.

  • Monthly visits
    9.8K

    ▲ 48.4% vs previous month

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Exsure (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Exsure

Premium access

Complete news archive for Exsure

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Exsure

Exsure was founded in 2021 and raised its 1st funding round 4 years after it was founded.

Exsure is headquartered in Bhubaneswar, India. It is registered at Bhubaneswar, Odisha, India.

Abhishek Dutta is the CEO of Exsure, as recorded in our data. They have also founded this company.

Exsure is a funded company, having raised a total of $346.88K across 1 funding round to date. The company's 1st funding round was a Seed of $346.88K, raised on Jan 2025.

Exsure has 1 employees.

The primary company behind Exsure, Exsure Private Limited, reported revenue of β‚Ή7.4 Lakh for FY 2025, down 74% year on year.

Exsure was founded in 2021 and is based in Bhubaneswar, India. Operations are centered in the biotechnology sector, where an exosome-based platform for chemotherapeutic drug delivery is being developed. Anti-cancer drugs are targeted precisely to tumor and relapse-causing cells through this technology, minimizing impact on healthy cells. The focus remains on advancing nano-scale solutions for oncology applications.

Exsure offers EXOSURE, LEUCOSURE, and DENDROSURE.

Exsure has 1 investor. Key investors include Unicorn India Ventures.

Exsure operates through Exsure Private Limited.

The legal entities of Exsure currently have 2 directors, including Abhishek Dutta, Swastika Paul.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available